Biochemical Analysis of CaurSOD4, a Potential Therapeutic Target for the Emerging Fungal Pathogen Candida auris

Courtney E. Chandler, Francisco G. Hernandez, Marissa Totten, Natalie G. Robinett, Sabrina S. Schatzman, Sean X. Zhang, Valeria C. Culotta

Research output: Contribution to journalArticlepeer-review

Abstract

Candida auris is an emerging multidrug-resistant fungal pathogen. With high mortality rates, there is an urgent need for new antifungals to combat C. auris. Possible antifungal targets include Cu-only superoxide dismutases (SODs), extracellular SODs that are unique to fungi and effectively combat the superoxide burst of host immunity. Cu-only SODs are essential for the virulence of diverse fungal pathogens; however, little is understood about these enzymes in C. auris. We show here that C. auris secretes an enzymatically active Cu-only SOD (CaurSOD4) when cells are starved for Fe, a condition mimicking host environments. Although predicted to attach to cell walls, CaurSOD4 is detected as a soluble extracellular enzyme and can act at a distance to remove superoxide. CaurSOD4 selectively binds Cu and not Zn, and Cu binding is labile compared to bimetallic Cu/Zn SODs. Moreover, CaurSOD4 is susceptible to inhibition by various metal-binding drugs that are without effect on mammalian Cu/Zn SODs. Our studies highlight CaurSOD4 as a potential antifungal target worthy of consideration.

Original languageEnglish (US)
Pages (from-to)584-595
Number of pages12
JournalACS Infectious Diseases
Volume8
Issue number3
DOIs
StatePublished - Mar 11 2022

Keywords

  • Candida auris
  • copper
  • fungi
  • metalloenzyme
  • superoxide
  • superoxide dismutase

ASJC Scopus subject areas

  • Infectious Diseases

Fingerprint

Dive into the research topics of 'Biochemical Analysis of CaurSOD4, a Potential Therapeutic Target for the Emerging Fungal Pathogen Candida auris'. Together they form a unique fingerprint.

Cite this